TRAF5 and melanoma: Recently, miR-26b-5p has been shown to target the MAPK and AKT/mTOR signaling pathways by binding to the 3′ UTR of TRAF5 or TRIM44, respectively [120,121], which are involved in the malignant progression of melanoma cells.